Skip to main content
. 2018 Mar 30;75(13):2303–2319. doi: 10.1007/s00018-018-2804-1

Fig. 3.

Fig. 3

Putative targets for therapeutic intervention in the Hippo pathway. Summary of the positive and negative regulators of Hippo kinases and YAP/TAZ, respectively. Activating components’ upstream of YAP/TAZ is in green, and inhibitory components are in red

HHS Vulnerability Disclosure